IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. - Wikidata - awgldk - TriplyDB

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

http://www.wikidata.org/entity/Q34744565

about

Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection Natural history and clinical response: "it's the virus, stupid, or is it the host?"STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver Future classes of hepatitis C virus therapeutic agents Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection Clinical utility of pharmacogenomics in the management of hepatitis C.IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability.Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.Detection of allele specific differences in IFNL3 (IL28B) mRNA expression EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.KPP: KEGG Pathway Painter Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C Recent advances in the anti-HCV mechanisms of interferon.Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.PharmGKB summary: peginterferon-α pathway.Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.

P2860

Q26745585-A7CC614C-5DE6-479F-9B48-FEC61CF816AD Q26745984-DCF63CD4-4ED8-4FD9-B667-B5B7ADBA02EB Q26784252-D115727A-F6E7-4DFA-A4ED-57CD8DFD1565 Q26824094-EC3DFF58-4C39-4B54-89B8-3ADCBD71CDBD Q27000742-EFEA07B3-7773-4063-A317-C0A64C616625 Q27009321-69020B95-2E8E-4A3F-BF26-6BAAEE1F6061 Q27307732-AAB7E5DC-7479-436A-9D70-C0B096D6CCB1 Q33786026-57C43647-C988-4213-8220-BDD2E30A0ABB Q33867243-9ED802BD-5BF7-46E1-BB28-92C24128CC04 Q33887705-1CB32C3D-99D1-482D-B43C-1530C69B1786 Q34008754-07E47F7E-66FA-4C85-951E-20C2A27A191E Q34010288-E498B592-4964-49BA-820C-30B893B4547F Q34049322-E0CC8EC6-7F7F-4C43-9D41-28955AF5F0FD Q34256897-3D82F7D7-BBF4-4724-A808-92B6EFBBA5F5 Q34282251-8053C2B4-FAB5-469B-8A8B-637276C2F330 Q34464613-A5FDDF1B-0595-4666-8B3D-44320712A371 Q34504772-7871612C-F094-4B2F-A8F7-3782DF7003D4 Q34575747-E27F24BA-E373-45E1-B298-7A3679ED2DDA Q34750577-D95D9390-A419-41FF-956C-6A11DC532DE4 Q34760439-0D8D0338-DAA3-4021-B548-CC4B93E9BC83 Q35111044-9CCB84D5-D814-4D39-ABC5-52F1D865768C Q35151509-0DE71E61-8FBD-4A85-A5B8-BF0FB3B7AB6A Q35153222-BC4BB6C1-41FD-4AC8-9EAF-ED0033F8FB93 Q35208006-3DDF9995-43A1-4D51-ACCD-82CFFAA225D5 Q35306683-EE5D1D19-51AF-45E8-B4E4-459AAF8C3079 Q35602911-B83FD904-7F87-4109-A291-2CD3BFF6A4D5 Q35602985-8234A5E0-51AB-4F93-A88B-4430F7BB3FA3 Q35626712-20A6CF2F-B810-4B51-9E1A-9F7827001964 Q35749502-4CE02BE7-62D7-4DB7-A692-443A3F218FD8 Q36208380-5E6166CA-2C98-449C-98BD-C98E17931756 Q36237584-0122048D-141F-41B8-B245-2E7CFCEB7A29 Q36478562-CEB38760-9D93-4226-854B-C51A7F655E67 Q36590755-F2728742-BDD0-463F-893A-73E7C0AE755C Q36600070-460057BE-5D0A-4B58-8473-1AC8C5C1F871 Q36628598-C7414A85-A16C-4E5F-85E9-365C2B1F91E5 Q36829191-093BF6AB-3DC3-449C-97DB-5F582D279BF2 Q37150565-CB69CE12-2B93-4064-A3FF-14561223DD81 Q37285273-D68ED8E7-E0F5-4C0E-9BCA-F24E82BEFDBB Q37400658-C4779D64-3D44-4318-B793-70343CB9EFCC Q37540221-34EAC5E5-3009-4D20-B7C4-DBBEE6F134C5

P2860

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

http://www.wikidata.org/entity/Q34744565

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@ast

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@en

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@nl

type

label

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@ast

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@en

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@nl

prefLabel

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@ast

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@en

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@nl

P1433

Q34744565-2FF20C2F-7618-4B8D-9C7D-BA5ADE1C2B32

P1476

Q34744565-2E2DC87C-71ED-4599-AF45-8CD0B12E2248

P2093

Q34744565-1C734DAC-9F9E-41C0-A9FB-3670FD606ABB

Q34744565-36A926F9-26F9-467F-996A-1148EAC7EBF2

Q34744565-3DF062F5-1175-4B0A-9F70-DC33B571FDA1

Q34744565-4F00C9A9-9DB5-49D8-86DD-E618796C581F

Q34744565-6E90A914-9569-4D70-8237-755D7E0C884A

Q34744565-79378B38-4EC3-479C-AC10-BA302B6F9B0F

Q34744565-D947161C-EB38-4CB5-A782-1E8D80189B41

Q34744565-E6D91A36-C9DA-40A3-936B-515CDB70D2CE

Q34744565-EB5EFC7D-476F-4190-A1F1-17B0736EF7AB

P2860

Q34744565-23804C34-A738-4D06-9010-D22422C488C6

Q34744565-26A7091B-8CA7-4A40-9B19-6FEAF2DE08B1

Q34744565-2AC66A1B-BCF9-4520-875B-7BF5204EEC08

Q34744565-34F37A52-959D-44EA-A26A-B68F31CF88AE

Q34744565-3CFF4276-81B9-440F-A991-DA9ECFB67CAC

Q34744565-47D35B0A-83D4-4FDC-BAAE-F74B909EC5CD

Q34744565-4B52AFAB-56A6-4C90-886D-67C42A18DDAB

Q34744565-4F111BB4-1D6E-4CD1-BFA9-DAA0CBF18ED9

Q34744565-6132C1B6-08C7-4E88-8902-2C18B3336099

Q34744565-62DBD90C-E72A-4C72-BAC1-4E50728B6EB6

P304

Q34744565-2B2DE5D3-74F4-4FEB-A066-12B13481A0A6

P31

Q34744565-C617124D-8BD1-4240-AC06-438FB41EA70A

P356

Q34744565-7CD59DD7-ED4E-403F-A06D-6163D4253773

P433

Q34744565-8287AB51-178B-4C36-89B8-9CC711B0E6AD

P478

Q34744565-BC97EE13-B66F-48C6-A322-46EAEC4139E7

P50

Q34744565-FBB95717-9601-4DB3-858A-129528526402

P577

Q34744565-D9C2B703-0C2C-4C09-BBAC-34A71076DC5F

P5875

Q34744565-3036D78C-74AC-464E-AF45-2B2C59BE2F58

P698

Q34744565-AC1777CB-39E4-4420-BCE4-43AE956391E0

P932

Q34744565-A7182DA7-0399-4104-B1D0-98445B22A440

P356

J.JHEP.2010.11.019

P1433

Journal of Hepatology

P1476

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

@en

P2093

Dahlene N Fusco

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Kaku Goto

http://www.w3.org/2001/XMLSchema#string

Lee F Peng

http://www.w3.org/2001/XMLSchema#string

Leiliang Zhang

http://www.w3.org/2001/XMLSchema#string

Nikolaus Jilg

http://www.w3.org/2001/XMLSchema#string

Run-Xuan Shao

http://www.w3.org/2001/XMLSchema#string

Wen-Chi Chen

http://www.w3.org/2001/XMLSchema#string

Wenyu Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Lambda interferon inhibits hepatitis B and C virus replication.

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

Replication of hepatitis C virus

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

P304

289-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2010.11.019

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Raymond T Chung

P577

2010-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49673108

http://www.w3.org/2001/XMLSchema#string

P698

21147189

http://www.w3.org/2001/XMLSchema#string

P932

3068235

http://www.w3.org/2001/XMLSchema#string